Cedaron Medical Inc El Macero, CA - 95618

Cedaron Medical Inc is categorized under Commercial Medical Research in El Macero, CA and active since 1990.

Cedaron Medical Inc was established in 1990, and today employs 1 to 4, earning $50.000.000 to $99.999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 4234501 by the NAICS.

If you are seeking more information, feel free to contact Karen Bond, Chief Executive Officer at the company’s single location by writing to 1655 Da Vinci Court, El Macero, California CA 95618 or by phoning (530) 758-7007. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cedaron Medical Inc
Contact Person: Karen Bond, Chief Executive Officer
Address: 1655 Da Vinci Court, El Macero, California 95618
Phone Number: (530) 758-7007
Website Address: cedaron.com
Annual Revenue (USD): $50.000.000 to $99.999.999
Founded: 1990
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 4234501
Share This Business:

Cedaron Medical Inc was started in 1990 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 4234501. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000.000 to $99.999.999 per annum.

Feel free to contact Karen Bond, Chief Executive Officer for inquiries that concern Cedaron Medical Inc by calling the company number (530) 758-7007, as your correspondence is most welcome. Additionally, the physical location of the single location of Cedaron Medical Inc can be found at the coordinates 38.53708,-121.73238 as well as the street address 1655 Da Vinci Court in El Macero, California 95618.

For its online presence, you may visit Cedaron Medical Inc’s website at cedaron.com and engage with its social media outlets through on Twitter and on Facebook.